Baszucki Group Funds UAB Study Evaluating Ketogenic Therapy for Bipolar Disorder in Rural Alabama Baszucki Group has announced funding for a new clinical study investigating the potential psychiatric and metabolic effects of ketogenic therapy in people living with bipolar disorder…
Kazmira Therapeutics Partners With CareValidate to Expand Access to Prescription, THC-Free CBD Therapy Across the U.S. Kazmira Therapeutics, the company behind Kazmira Pharmacy and the Cope Now telehealth platform, has announced a partnership with CareValidate, a digital health infrastructure provider…
GC Biopharma to Present New IVIG Product Analyses and Host Patient Advocacy Symposium at IgNS 2026 Conference GC Biopharma USA, Inc., a company specializing in plasma-derived products, has announced plans to present two new scientific analyses and host a patient…
Stoke Therapeutics Presents STK-002 Preclinical and Clinical Data at AAO 2026, Advancing RNA-Based Approach for Autosomal Dominant Optic Atrophy Stoke Therapeutics, Inc., a biotechnology company focused on restoring protein expression by harnessing the body’s potential with RNA medicine, has announced…
Corcym Reports Positive Seven-Year Mid-Term Data for Perceval Plus Sutureless Aortic Valve in MANTRA Clinical Study Corcym, a global medical device company focused on cardiac surgery, has announced positive mid-term clinical findings from a sub-analysis of its MANTRA clinical study…
INBRAIN Neuroelectronics Completes MINIGRAPH Project, Advancing Graphene-Based Brain-Computer Interfaces and Robotic Neural Implantation INBRAIN Neuroelectronics, a clinical-stage neurotechnology company developing graphene-based brain-computer interface (BCI) therapeutics, has announced the successful completion and results of MINIGRAPH, a European Innovation Council (EIC)-funded research…
Bridge Neurotech Emerges from Stealth with Non-Invasive Brain-Computer Interface Vision, Partners with Butterfly Network Bridge Neurotech, a company developing a completely non-invasive brain-computer interface (BCI), has emerged from stealth with a mission to explore brain-computer interaction without the need for…
RoslinCT Secures Up to £7.25 Million Scottish Enterprise Grant to Accelerate Digital Transformation of Cell Therapy Manufacturing RoslinCT, a global Contract Development and Manufacturing Organization (CDMO) specializing in advanced cell therapies, has been awarded a Research & Development grant from…
Nitto Avecia’s Milford Facility Receives FDA No Action Indicated Classification Following cGMP Inspection Nitto Avecia, a contract development and manufacturing organization (CDMO) specializing in oligonucleotide therapeutics, announced that the U.S. Food and Drug Administration (FDA) has classified its recently completed…
Exthymic Receives Up to $25 Million ARPA-H Award to Advance LITTLESTAR Cell Therapy Manufacturing Device Exthymic Corporation, a biotechnology company developing technologies designed to expand access to engineered cell therapies, announced that it has been awarded a contract from the…
I2Pure Expands Leadership and Scientific Team to Support Molecular Iodine Manufacturing and Research Growth I2Pure Corp., a biotechnology company focused on patented molecular iodine (I₂) technology for antimicrobial and antiseptic applications, has announced the addition of three experienced professionals to…
Singleton Associates and Blue Cross and Blue Shield of Texas Reach Multi-Year Agreement to Maintain In-Network Radiology Access Singleton Associates, P.A. (Singleton Associates), a radiology practice affiliated with Radiology Partners, and Blue Cross and Blue Shield of Texas (BCBSTX) have…